Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 592654

Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.


Ring, Johaness; Alomar, A; Bieber, Thomas; Deleuran, M; Fink-Wagner, A; Gelmetti, G; Gieler, U; Lipozenčić, Jasna; Luger, Thomas; Oranje, AP et al.
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. // JEADV. Journal of the European Academy of Dermatology and Venereology, 26 (2012), 9; 1176-1193 doi:10.1111/j.1468-3083.2012.04636x (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 592654 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.

Autori
Ring, Johaness ; Alomar, A ; Bieber, Thomas ; Deleuran, M ; Fink-Wagner, A ; Gelmetti, G ; Gieler, U ; Lipozenčić, Jasna ; Luger, Thomas ; Oranje, AP ; Schaefer, T ; Schwennesen T ; Seidenari, S ; Simon, D ; Staender, S ; Stingl, Georg ; Szalai, Zsuzsanna ; Szepietowski, Jacek ; Taieb, A ; Werfel, Thomas ; Wollenberg, A ; Darsow, Uwe ;

Izvornik
JEADV. Journal of the European Academy of Dermatology and Venereology (0926-9959) 26 (2012), 9; 1176-1193

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Treatment; atopic eczema; atopic dermatitis; Guidelines; DELPHI procedures

Sažetak
The existing evidence for treatment of atopic eczema (atopic dermatitis, AE) is evaluated using the national standard Appraisal of Guidelines Research and Evaluation. The consensus process consisted of a nominal group process and a DELPHI procedure. Management of AE must consider the individual symptomatic variability of the disease. Basic therapy is focused on hydrating topical treatment, and avoidance of specific and unspecific provocation factors. Anti-inflammatory treatment based on topical glucocorticosteroids and topical calcineurin inhibitors (TCI) is used for exacerbation management and more recently for proactive therapy in selected cases. Topical corticosteroids remain the mainstay of therapy, but the TCI tacrolimus and pimecrolimus are preferred in certain locations. Systemic immune- suppressive treatment is an option for severe refractory cases. Microbial colonization and superinfection may induce disease exacerbation and can justify additional antimicrobial treatment. Adjuvant therapy includes UV irradiation preferably with UVA1 wavelength or UVB 311 nm. Dietary recommendations should be specific and given only in diagnosed individual food allergy. Allergen-specific immunotherapy to aeroallergens may be useful in selected cases. Stress-induced exacerbations may make psychosomatic counselling recommendable. ‘Eczema school’ educational programs have been proven to be helpful. Pruritus is targeted with the majority of the recommended therapies, but some patients need additional antipruritic therapies.

Izvorni jezik
Engleski



POVEZANOST RADA


Projekti:
218-0000000-3657 - Maligni epidermalni kožni tumori u Hrvatskoj (Lipozenčić, Jasna, MZOS ) ( CroRIS)

Ustanove:
Akademija medicinskih znanosti

Profili:

Avatar Url Jasna Lipozenčić (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Ring, Johaness; Alomar, A; Bieber, Thomas; Deleuran, M; Fink-Wagner, A; Gelmetti, G; Gieler, U; Lipozenčić, Jasna; Luger, Thomas; Oranje, AP et al.
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. // JEADV. Journal of the European Academy of Dermatology and Venereology, 26 (2012), 9; 1176-1193 doi:10.1111/j.1468-3083.2012.04636x (međunarodna recenzija, članak, znanstveni)
Ring, J., Alomar, A., Bieber, T., Deleuran, M., Fink-Wagner, A., Gelmetti, G., Gieler, U., Lipozenčić, J., Luger, T. & Oranje, A. (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.. JEADV. Journal of the European Academy of Dermatology and Venereology, 26 (9), 1176-1193 doi:10.1111/j.1468-3083.2012.04636x.
@article{article, author = {Ring, Johaness and Alomar, A and Bieber, Thomas and Deleuran, M and Fink-Wagner, A and Gelmetti, G and Gieler, U and Lipozen\v{c}i\'{c}, Jasna and Luger, Thomas and Oranje, AP and Schaefer, T and Seidenari, S and Simon, D and Staender, S and Stingl, Georg and Szalai, Zsuzsanna and Szepietowski, Jacek and Taieb, A and Werfel, Thomas and Wollenberg, A and Darsow, Uwe}, year = {2012}, pages = {1176-1193}, DOI = {10.1111/j.1468-3083.2012.04636x}, keywords = {Treatment, atopic eczema, atopic dermatitis, Guidelines, DELPHI procedures}, journal = {JEADV. Journal of the European Academy of Dermatology and Venereology}, doi = {10.1111/j.1468-3083.2012.04636x}, volume = {26}, number = {9}, issn = {0926-9959}, title = {Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.}, keyword = {Treatment, atopic eczema, atopic dermatitis, Guidelines, DELPHI procedures} }
@article{article, author = {Ring, Johaness and Alomar, A and Bieber, Thomas and Deleuran, M and Fink-Wagner, A and Gelmetti, G and Gieler, U and Lipozen\v{c}i\'{c}, Jasna and Luger, Thomas and Oranje, AP and Schaefer, T and Seidenari, S and Simon, D and Staender, S and Stingl, Georg and Szalai, Zsuzsanna and Szepietowski, Jacek and Taieb, A and Werfel, Thomas and Wollenberg, A and Darsow, Uwe}, year = {2012}, pages = {1176-1193}, DOI = {10.1111/j.1468-3083.2012.04636x}, keywords = {Treatment, atopic eczema, atopic dermatitis, Guidelines, DELPHI procedures}, journal = {JEADV. Journal of the European Academy of Dermatology and Venereology}, doi = {10.1111/j.1468-3083.2012.04636x}, volume = {26}, number = {9}, issn = {0926-9959}, title = {Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.}, keyword = {Treatment, atopic eczema, atopic dermatitis, Guidelines, DELPHI procedures} }

Časopis indeksira:


  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font